Yingli Ma - Mar 15, 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role: CHIEF TECHNOLOGY OFFICER
Signature: /s/ Jun Yoon, Attorney-in-Fact
Stock symbol: GPCR
Transactions as of: Mar 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/19/2024, 04:48 PM
Previous filing: Feb 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GPCR	Ordinary Shares	Award	$0	+36.7K		$0.00	36.7K	Mar 15, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GPCR	Stock Option (right to buy)	Award	$0	+91.5K		$0.00	91.5K	Mar 15, 2024	Ordinary Shares	91.5K	$35.25	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates.
F2	1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.